Banco Bilbao Vizcaya Argentaria’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-10,000	Closed	-$479K	–	780
2020 Q2	$479K	Hold	10,000	–	–	0.02%	560
2020 Q1	$629K	Buy	+10,000	New	+$899K	0.02%	451

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's ICPT Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2020, closing a stake of 10,000 shares — an estimated $479K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in ICPT in Q1 2020 and held it in 2 quarters. The position peaked at $629K in Q1 2020. 177 funds tracked by Wall St. Rank hold ICPT as of Q3 2020.

Banco Bilbao Vizcaya Argentaria reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Banco Bilbao Vizcaya Argentaria sold 10,000 Intercept Pharmaceuticals, Inc. shares in Q3 2020, an estimated $479K.
Banco Bilbao Vizcaya Argentaria first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2020 and held it in 2 quarters.
Banco Bilbao Vizcaya Argentaria's Intercept Pharmaceuticals, Inc. position peaked at $629K in Q1 2020.
177 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.